The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care - CRISPR Therapeutics (NASDAQ:CRSP), Avant Technologies (OTC:AVAI)

Issued on behalf of Avant Technologies Inc.VANCOUVER, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read, replace, and rewrite cellular behavior to combat age-related diseases and metabolic disorders. The cell harvesting infrastructure expanded to support next-generation cell and gene therapy manufacturing, creating momentum across platform ...